Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced Unresectable HER2-Negative Breast Carcinoma

Explore clinical trials studying Locally Advanced Unresectable HER2-Negative Breast Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Locally Advanced Unresectable HER2-Negative Breast Carcinoma trial results

Recruiting

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

NCT06179303

Conditions
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Unresectable HER2-Negative Breast Carcinoma, +3 more
Locations
  • Siteman Cancer Center at Washington University St Louis, Missouri, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions